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Objective: To develop a model for predicting postoperative hematocrit levels after uncomplicated hysterectomy.
Methods: In a retrospective study, data were analyzed from the Michigan Surgery Quality Collaborative for non-
emergent hysterectomies performed for benign indications among women aged at least 18 years between
January 1, 2012, and April 4, 2014. Linear mixed models were used for univariate and multivariate analyses.
Results: The model was developed with data from 4747 hysterectomies and validated on 1184 cases. In the
mixed multivariate analysis, higher postoperative day 1 (POD1) hematocrit levels were associated with higher
weight (B= 0.03222, P b 0.001), higher preoperative hematocrit (B= 0.6587, P b 0.001), and non-vaginal hys-
terectomy (B= 0.2815, P= 0.0055). Lower POD1 hematocrit was associated with higher preoperative platelet
count (B=−0.00457, P b 0.001), greater estimated blood loss (B=−0.00652, P b 0.001), and larger intraoper-
ative crystalloid volume (B=−0.3303, P b 0.001). The final model predicted POD1 hematocrit within 4% points
of the actual value for 91.7% of cases in the validation set. Conclusion: Use of the model after uncomplicated
hysterectomy might help to support the practice of selectively conducting postoperative hematocrit tests after
hysterectomy in a clinically thoughtful and cost-effective manner.
© 2015 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.1. Introduction
Hysterectomy is the most common major gynecologic surgery
performed in theUSA, and the secondmost common surgery performed
for women of reproductive age (after cesarean delivery) [1]. Evidence-
based guidelines exist for preoperativemanagement, including prophy-
laxis against surgical-site infections and venous thromboembolism [2].
By contrast, postoperative protocols are largely determined by historical
practices and expert opinion rather than by scientific evidence.
Although numerous textbooks recommend blood tests—including a
complete blood count—as part of the routine postoperative evaluation
of a patient, several studies suggest that such routine laboratory testing
rarely results in meaningful differences in clinical outcomes [3,4].
Studies have also attempted to identify factors that predict blood
counts. One looking at patients undergoing cardiopulmonary bypass
surgery [5] identified various factors including older age, female sex,
Hispanic or non-white ethnic origins, lower body surface area, and
high creatinine as independent predictors of a hematocrit level of
21.9% or lower. Petersen et al. [6] looked at predictors of postpartum
hematocrit after vaginal delivery and found that an estimated blood
loss of more than 500 mL, Hispanic ethnic origin, and third- or fourth-Department of Obstetrics and
enter Dr., SPC 5276, Ann Arbor,
4 647 9727.
son).
and Obstetrics. Published by Elsevier Idegree perineal laceration were objective predictors of a hematocrit
level of less than 26% [6]. The aim of these previous studies was to be
able to predict which patients would have hematocrit values at or
below a certain threshold; however, few studies have provided a
model capable of accurately predicting a postoperative blood count
value. To our knowledge, the only published study has been based on
orthopedic procedures with a study sample of which less than 40%
were women [7].
Given the lack of evidence supporting routine postoperative labora-
tory tests after benign gynecologic surgery, the aim of the present study
was to develop a mathematical model that can accurately predict
postoperative hematocrit level after hysterectomy for benign indica-
tions. Such a model might not only limit the number of unindicated
procedures that patients undergo after hysterectomy, but also decrease
unnecessary resource utilization.2. Materials and methods
In a retrospective study, data were analyzed from theMichigan Sur-
gical Quality Collaborative (MSQC) [8] for hysterectomies performed
across the state of Michigan, USA, between January 1, 2012, and April
4, 2014. Informed consentwas not required because theMSQC database
contains de-identified data. The University of Michigan Institutional
Review Board granted “Not Regulated” status to the present
study j(HUM00073978).reland Ltd. All rights reserved.
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community hospitals across Michigan and is funded by the Blue Cross
Blue Shield of Michigan/Blue Care Network. Trained nurse data abstrac-
tors prospectively collate data on patient characteristics, intraoperative
processes of care, and 30-day postoperative outcomes, from patients
undergoing surgery at participating hospitals.
For the present study, data were reviewed from all women aged
18 years or older who underwent a hysterectomy during the study pe-
riod at an MSQC member hospital. To model postoperative hematocrit
levels after uncomplicated hysterectomies performed for benign indica-
tions, only patients with current procedural terminology codes and In-
ternational Classification of Diseases, Clinical Modification 9 codes
consistent with benign, non-emergent hysterectomy for a non-
obstetric indication were considered for the analysis. The inclusion
criteria were a preoperative hematocrit level greater than or equal to
20%, postoperative day 1 (POD1) hematocrit greater than or equal to
15%, intraoperative crystalloid infusion less than 5 L, no intraoperative
colloid infusion, estimated blood loss (EBL) of 10–500mL, operative du-
ration greater than or equal to 15 minutes, preoperative platelet count
greater than or equal to 100 000/μL, body mass index (calculated as
weight in kilograms divided by the square of height in meters) greater
than or equal to 15, and an American Society for Anesthesiologists phys-
ical status classification of 1 (normal, healthy patient), 2 (mild systemic
disease), or 3 (severe systemic disease). Patients were excluded if they
had a diagnosis of cancer as a result of the surgery, cancer as an indica-
tion for the surgery, preoperative sepsis, other concomitant major sur-
geries (e.g. colectomy, or liver or kidney surgery), or red-blood-cell or
platelet transfusion preoperatively, intraoperatively, or postoperatively.
To build and test the hematocrit prediction model, the study sample
was randomly divided into a model development subset and a
validation subset, respectively. Modeling and statistical analyses were
done via SAS version 9.4 (SAS Institute, Cary, NC, USA) using “proc
mixed,” “proc reg” with “vif” and “collin” options, “proc anova,” and
“proc freq”with “chisq” option, as appropriate. Comparisons of contin-
uous and categorical variables between the two subsets were done via
one-way analysis of variance and χ2 tests, respectively.
To derive themodel, patient demographics and preoperative, intraop-
erative, and postoperative characteristics associated with blood loss and
fluid balance were selected as the independent variables (Box 1). Univar-
iate associations between independent variables and the postoperative
hematocrit level were analyzed, and variables that were significant at
an α level of 0.10 or less were entered into a multivariable linear mixed
model, with random site effects to account for clustered data. This multi-
variable linear mixed model was subjected to stepwise selection to iden-
tify a subset of significant model variables with a P value of less than 0.05
in a type III test offixed effects. Thefixed effectswere retained only if their
addition to themodel significantly improvedmodel fit (i.e. decreased the
Akaike information criterion by a value consistent with a P value of less
than 0.05 for a χ2 distribution with 1 degree of freedom). The retained
variables were analyzed for collinearity.
Predicted hematocrit levels were calculated for the randomly select-
ed validation subset, which comprised 20% of the eligible hysterectomy
cases and did not include any data used in the model development
subset. The predicted value for each patient was compared with the ac-
tual postoperative hematocrit level for that patient, and the differenceBox 1
Variables analyzed within the linear mixed model.
Demographic characteristics Preoperative
Age a, ethnic origin a, body mass index a,
height, weight a, diabetes, smoking status a,
ASA class, functional status
Hematocrit a, platelet coun
Abbreviations: ASA, American Society of Anesthesiologists; EBL, estima
aVariables independently predictive of postoperative day 1 hematocrit levbetween the two values was calculated to assess the accuracy of the
model for the purposes of prediction.
3. Results
Demographic and perioperative data were obtained for 13 745
women who underwent hysterectomy at 50 hospitals participating in
the MSQC during the study period. After excluding complicated
hysterectomies, 9172 (66.7%) cases were identified as uncomplicated
hysterectomies. Of the uncomplicated hysterectomies, 1818 (19.8%)
had no postoperative hematocrit value in the database, and 1420
(15.5%) had their lowest postoperative hematocrit in the database
recorded on a date that was not POD1. As a result, 5934 (64.7%) uncom-
plicated hysterectomies were eligible for analysis, 4750 (80.0%) of
which were randomly allocated into a model development dataset
and 1184 (20.0%) to a validation dataset. Three caseswere subsequently
found to lack preoperative body weight; as a result, the final number in
the model development dataset was 4747.
The subsets were similar in terms of patient age, body mass index,
ethnic origin, and smoking status (Table 1). The difference in distribu-
tion of route of hysterectomy between subsets reached statistical
significance (P = 0.05) with a slightly lower proportion of abdominal
hysterectomies and greater proportion of vaginal hysterectomies in
the model validation subset than in the model development subset.
In themixedmultivariable linear regression, factors associated with a
higher POD1 hematocrit included higherweight, higher preoperative he-
matocrit, and non-vaginal hysterectomy route. Variables associated with
a lower POD1 hematocrit value included higher preoperative platelet
count, higher EBL, and larger volumeof intraoperative crystalloid infusion
(Table 2). Analysis of the variables included in thefinalmodel revealedno
significant collinearity (data not shown).
For purposes of validation, the ability of the model to predict POD1
hematocrit to a value within 1% to within 5% points was tested
(Table 3). The model predicted the POD1 hematocrit level to ±5%
points for 100%, ±4% points for 91.7%, ±3% points for 81.2%, ±2%
points for 62.9%, and ±1% points for 34.8% of cases. The squared
correlation coefficient (R2) of the model (calculated for the whole
study sample including the validation subset) was 0.53.
Given the finding that a vaginal hysterectomy route was associated
with lower POD1 hematocrit, the change in hematocrit (measured as
the difference between POD1 hematocrit and preoperative hematocrit)
was analyzed by route of hysterectomy. Themean change in hematocrit
was significantly greater for cases of vaginal hysterectomy versus
other routes of hysterectomy (−6.40% ± 2.93% vs −5.82% ± 2.92%;
P b 0.001). By route of hysterectomy, overall mean EBL was highest
for abdominal (201.2 ± 128.0 mL), followed by vaginal (141.0 ±
102.2 mL), laparoscopic-assisted vaginal hysterectomy (130.5 ±
105.8mL), and then laparoscopic hysterectomy (91.3±78.5mL). How-
ever, vaginal hysterectomy had significantly greater EBL as compared
with all other routes (141.0± 102.2mL vs 126.9± 108.4 mL; P b 0.001).
4. Discussion
In the present study, a mathematical model has been developed to
predict POD1 hematocrit levels after hysterectomy for benign disease.Intraoperative Postoperative
t a Route of hysterectomy a, type of anesthesia,
temperature a, intraoperative crystalloid volume a,
EBL a, urine output a, surgical time a
Temperature
ted blood loss.
els when analyzed by bivariate logistic regression.
Table 3
Accuracy of themodel in predicting postoperative day 1 hematocrit level af-
ter hysterectomy.
Accuracy of predicted
hematocrit, % points
No. (%) of predicted cases
within range of actual value
±1 412 (34.8)
±2 745 (62.9)
±3 961 (81.2)
±4 1086 (91.7)
±5 1184 (100.0)
Table 1
Demographic characteristics of the model development and validation subsets.a
Demographics Model development subset
(n = 4747)
Validation subset
(n = 1184)
P valueb
Age, y 47.7 ± 11.3 47.5 ± 11.1 0.57
BMI 30.3 ± 7.0 30.4 ± 7.0 0.22
Ethnic origin
White 3705 (78.1) 938 (79.2) 0.85
Black 676 (14.2) 160 (13.5) –
Other 55 (1.2) 13 (1.1) –
Unknown 311 (6.6) 73 (6.2) –
Smoker 1106 (23.3) 284 (24.0) 0.60
Type of hysterectomy
Abdominal 954 (20.1) 207 (17.5) 0.05
Laparoscopic 2,047 (43.1) 508 (42.9) –
Vaginal 721 (15.2) 213 (18.0) –
LAVH 1025 (21.6) 256 (21.6) –
Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by the
square of height in meters); LAVH, laparoscopic-assisted vaginal hysterectomy.
a Values are given as mean ± SD or number (percentage).
b By χ2 test for categorical variables and independent t test for continuous variables.
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because they have a biological role that plausibly might affect POD1
hematocrit values. Three factors were identified to predict higher
POD1 hematocrit: preoperative weight, preoperative hematocrit, and
route of hysterectomy other than vaginal. The precedence for including
these variables in the model is supported by previous studies.
For example, total blood volume, of which hematocrit represents the
percentage of red blood cells, can be calculated on the basis of height
and weight, and increases in both correlate with increased blood
volume [9]. Thus, women with a higher preoperative weight would
have greater overall blood volume such that small shifts in fluid have
less impact. Similarly, for any given blood loss, a higher preoperative
hematocrit can be expected to correlate with higher POD1 hematocrit,
as compared with a lower starting hematocrit value. Lastly, using
vaginal hysterectomy as the referent group, all other hysterectomy
routeswere correlatedwith higher POD1 hematocrit levels. This finding
is probably related to greater intraoperative blood loss with vaginal
hysterectomy, as reported in other studies [10–12].
In the present study, EBL was significantly greater among women
undergoing vaginal versus non-vaginal hysterectomy and, similarly,
there was a greater decrease in hematocrit postoperatively after vaginal
hysterectomy. Two randomized controlled trials comparing the route of
hysterectomy found that vaginal hysterectomy had greater intraopera-
tive blood loss than did abdominal hysterectomy [10,11]. Although
the difference did not reach statistical significance in either study, the
sample sizes were small (the largest group had 40 patients), and
therefore were probably underpowered to detect this difference.
Similarly, Bogani et al. [12] reported significantly greater EBL for vaginal
versus laparoscopic hysterectomy for benign indications. The greaterTable 2
Variables and their coefficients in the final multivariable model predicting POD1
hematocrit level after hysterectomy.
Variable Coefficient P valuea
POD1 hematocrit intercept 7.2644 b0.001
Preoperative hematocrit (in % points) 0.6587 b0.001
Weight (in kg) 0.03222 b0.001
EBL (in mL) −0.00652 b0.001
Intraoperative crystalloid (in L) −0.3303 b0.001
Preoperative platelet count (in × 1000/μL) −0.00457 b0.001
Laparoscopic, LAV, or abdominal hysterectomyb 0.2815 0.0055
Abbreviations: POD1, postoperative day 1; EBL, estimated blood loss; LAV, laparoscopic-
assisted vaginal.
a By type III tests for fixed effects.
b The referent was vaginal hysterectomy.EBL, and therefore greater drop in postoperative hematocrit, observed
during vaginal hysterectomymight be due to initiation of the procedure
with a colpotomy (which can subsequently bleed throughout the oper-
ation), decreased utilization of electrosurgical coagulation as compared
with other routes, limited visualization of blood loss, and increased
concomitant procedures (e.g. prolapse or incontinence procedures).
Three variables in the present model were predictive of lower POD1
hematocrit: higher EBL at the time of surgery, greater intraoperative
crystalloid volume, and higher preoperative platelet count. Greater
EBL at the timeof surgerywould be expected to lower POD1hematocrit,
as would greater volumes of crystalloid owing to dilutional effects.
Although the association between higher preoperative platelet count
and lower postoperative hematocrit is not clear, a plausible explanation
is that higher preoperative platelet counts may indicate dehydration,
and therefore aggressive intraoperative fluid resuscitation might lead
to greater dilutional effects.
The present study has several limitations. First, data were limited to
what was available in the MSQC database and it was not possible to
collect missing data. Second, the analysis was intentionally restricted
to benign, uncomplicated hysterectomies with an intraoperative blood
loss of 500 mL, which limits the generalizability of the findings. Third,
variation between study sites might affect the final model, although
the data were analyzed by mixed modeling to account for this effect.
Last, the R2 and validation outcomes indicate that the model accounts
for only approximately 50% of the variation in POD1 hematocrit. This
suggests that there are other factors that affect postoperative blood
counts that were not identified in the present study.
The strengths of the present study include the use of a large state-
wide database representative of various clinical settings. Data in the
MSQC database are collected using a validated methodology and by
specially trained and dedicated nurse data abstractors. In addition,
the use of mixed modeling for statistical analyses controlled for
systematic differences among study sites, thereby improving the
model’s generalizability. Last, the model was validated using 20% of
cases, none of which was used in the initial model development
data set.
Although routinemeasurement of POD1 hematocrit after benign gy-
necologic procedures is common practice, neither the cost-effectiveness
nor the clinical utility of this practice is supported by evidence. Chamsy
et al. [13] have estimated that elimination of routine hemoglobin
testing after total laparoscopic hysterectomy would save more than
US$2.8 million annually in the USA. Because their study was limited to
one route of hysterectomy, healthcare savings would be expected to
be much higher if this routine practice were eliminated for all hysterec-
tomies performed for benign indications in the USA. Furthermore,
although one unnecessary postoperative hematocrit test might seem
innocuous, in actuality it can lead to more costly and more invasive
procedures for patients including repeat laboratory testing to validate
or refute prior testing, unnecessary imaging studies and radiation
exposure, surgical interventions, and delayed hospital discharge. De-
spite the additional interventions that may be incurred, it has been
clearly demonstrated that the practice of routine hematocrit testing
after benign gynecologic surgery does not improve outcomes [3,4].
Therefore, use of the present model could help to eliminate the practice
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ectomy for benign indications, thereby promoting both the practice of
evidence-based medicine and good stewardship of resources.
In summary, a model has been developed that might help to limit
unnecessary laboratory testing after benign hysterectomy. This model
should be used at the completion of surgery to calculate the expected
POD1 hematocrit. If the predicted hematocrit is within an acceptable
range and the surgeon has no concerns regarding the patient’s
condition, it would be reasonable to not carry out routine POD1 hemat-
ocrit testing. It must be emphasized, however, that thismodel should be
limited to cases of uncomplicated hysterectomy for benign disease
among hemodynamically stable patients where there is low suspicion
of bleeding complications. Patients who do not meet these criteria
should have an evaluation including relevant laboratory assessment
as indicated.
At the study institution, use of the present model has prompted
reassessment of the need for routine postoperative laboratory tests
after uncomplicated benign gynecologic surgery. As a result, standard
practice has been changed to review the need for a postoperative
hematocrit test immediately after surgery. Taking into account the
patient’s clinical history and intraoperative factors, clinicians discuss
whether management based on vital signs, urine output, and clinical
examination will be adequate and, if so, no postoperative hematocrit
test is conducted. By incorporating this model into standard practice,
postoperative laboratory testing has been reduced among patients
undergoing benign gynecologic surgery.
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